Elizabeth B Somers

Title: Innovations and Contributions of Elizabeth B Somers

Introduction

Elizabeth B Somers is a notable inventor based in West Grove, Pennsylvania. She has made significant contributions to the field of medical research, particularly in cancer diagnostics and treatment. With a total of three patents to her name, her work has the potential to impact the lives of many patients.

Latest Patents

One of her latest patents is focused on anti-folate receptor alpha antibodies and their uses. This patent describes antibodies and antigen-binding fragments that are specific for folate receptor alpha. It also includes related polynucleotides, expression vectors, and cells that express these antibodies. The methods provided in this patent are aimed at diagnosing folate receptor alpha-expressing cancers. They involve determining the amount of folate receptor alpha in a sample derived from a subject and comparing this level with a control sample.

Another significant patent involves methods for determining the prognosis of colorectal cancer. This patent outlines methods for assessing the risk of recurrence in patients diagnosed with colorectal cancer. It includes determining the expression levels of a panel of markers in tumor tissue samples and comparing the TAPPS score of the subject to a population of subjects diagnosed with colorectal cancer.

Career Highlights

Elizabeth has worked with prominent companies in the pharmaceutical industry, including Eisai R&D Management Co., Ltd. and Eisai Inc. Her experience in these organizations has contributed to her expertise in developing innovative solutions for cancer treatment and diagnostics.

Collaborations

Throughout her career, Elizabeth has collaborated with notable professionals in her field, including Daniel John O'Shannessy and Nicholas C Nicolaides. These collaborations have likely enhanced her research and development efforts.

Conclusion

Elizabeth B Somers is a pioneering inventor whose work in cancer diagnostics and treatment is making a significant impact. Her patents reflect her commitment to advancing medical science and improving patient outcomes.